Search research articles
Contact Us
Filters
Showing results (81-90 of 104) with videos related to
Page
of 11
Sort By:
American Journal of Hematology
|
May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of bone
Rahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Blood Cancer Journal
|
May 13, 2021
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
Joseph Mikhael, Karim Belhadj-Merzoug, Cyrille Hulin, et al.
Annals of Hematology
|
April 7, 2018
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients
Verónica González-Calle, Abigail Slack, Niamh Keane, et al.
Leukemia Research
|
October 17, 2013
The clinical significance of cereblon expression in multiple myeloma
Steven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Blood
|
October 12, 2017
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Shaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2019
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
Joseph Mikhael, Nofisat Ismaila, Matthew C Cheung, et al.
Expert Opinion on Investigational Drugs
|
July 14, 2025
Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions
Paul G Richardson, Elisabeth K O'Donnell, Peter O'Gorman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline
Lisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.
Journal of Medical Economics
|
May 9, 2025
The benefits of telehealth in promoting equity in blood cancer care - results of a multi-stakeholder forum and systematic literature review
Joseph Mikhael, Deanna Darlington, Bethany Howell, et al.
Blood
|
January 15, 2014
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study
Paul G Richardson, David S Siegel, Ravi Vij, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 104) with videos related to
Sort By:
Page
of 11
American Journal of Hematology
|
May 3, 2012
Trends and outcomes of modern staging of solitary plasmacytoma of bone
Rahma Warsame, Morie A Gertz, Martha Q Lacy, et al.
Blood Cancer Journal
|
May 13, 2021
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
Joseph Mikhael, Karim Belhadj-Merzoug, Cyrille Hulin, et al.
Annals of Hematology
|
April 7, 2018
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients
Verónica González-Calle, Abigail Slack, Niamh Keane, et al.
Leukemia Research
|
October 17, 2013
The clinical significance of cereblon expression in multiple myeloma
Steven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Blood
|
October 12, 2017
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Shaji Kumar, Jonathan L Kaufman, Cristina Gasparetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2019
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
Joseph Mikhael, Nofisat Ismaila, Matthew C Cheung, et al.
Expert Opinion on Investigational Drugs
|
July 14, 2025
Isatuximab for the treatment of multiple myeloma: current clinical advances and future directions
Paul G Richardson, Elisabeth K O'Donnell, Peter O'Gorman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline
Lisa K Hicks, Hans J Messersmith, Samer Al Hadidi, et al.
Journal of Medical Economics
|
May 9, 2025
The benefits of telehealth in promoting equity in blood cancer care - results of a multi-stakeholder forum and systematic literature review
Joseph Mikhael, Deanna Darlington, Bethany Howell, et al.
Blood
|
January 15, 2014
Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study
Paul G Richardson, David S Siegel, Ravi Vij, et al.
Page
of 11